Kernicterus
1st Edition
Published on 9. September 2010
Book
Hardback
XIV, 286 pages
978-1-4419-6554-7 (ISBN)
Description
Kernicterus (bilirubin encephalopathy) is a highly interesting example of metabolic encephalopathy. It fills all the characteristics of a metabolic encephalopathy in that it can develop rapidly, produces signature signs and symptoms, and is amenable to successful treatment. In the absence of treatment kernicterus can produce devastating sequelae and death.
The present volume will examine the biochemistry and physiology of bilirubin as well as its hepatic metabolism and renal excretion. Chapters will elaborate bodily disposition of bilirubin and its neuropathology. Both early treatments and current therapy will be discussed in detail. Phototherapy will be presented, and its efficacy and influence on incidence thoroughly examined.
Reviews / Votes
From the reviews:
"Hyperbilirubinemia and the prevention of development of neurological pathology and/ or death due to kernicterus in newborns is a significant concern for physicians and allied healthcare workers worldwide. . Kernicterus is a worthy addition to the clinical neuroscience literature as a treatise on a condition that preferentially attacks critical brain regions. . it should be read widely by clinicians and public health officers confronted by issues related to the early diagnosis, treatment and rehabilitation of individuals suffering from kernicterus." (Medical Science Books, May, 2011)More details
Series
Edition
1st Edition.
Language
English
Place of publication
Totowa
United States
Target group
Professional and scholarly
Research
Illustrations
XIV, 286 p.
Dimensions
Height: 241 mm
Width: 160 mm
Thickness: 23 mm
Weight
672 gr
ISBN-13
978-1-4419-6554-7 (9781441965547)
DOI
10.1007/978-1-4419-6555-4
Schweitzer Classification
Other editions
Additional editions
Person
Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL, USA. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 26th year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine.Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others
Content
Dedication page.- Preface.- Acknowledgement.- Key words.-Chapter 1 Prologue: Hyperbilirubinemia, kernicterus, and world health concerns.-Chapter 2 History of bilirubin.-Chapter 3 Biochemistry and physiology of bilirubin.- Chapter 4 Prematurity.- Chapter 5 Erythroblastosis fetalis.- Chapter 6 Gunn rats.- Chapter 7 Crigler-Najjar Syndrome.- Chapter 8 Neuropathology of kernicterus.- Chapter 9 Bilirubin and energy metabolism.- Chapter 10 Bilirubin and other biochemical changes.- Chapter 11 Jaundice and breast milk.- Chapter 12 Jaundice and malaria.- Chapter 13 Jaundice and congenital pyloric stenosis.- Chapter 14 Phototherapy for hyperbilirubinemia.- Chapter 15 Non phototherapy treatment.- Chapter 16 Hyperbilirubinemia revisited.- Chapter 17 Auditory brainstem response.- Chapter 18 Progressive familial intrahepatic cholestasis.- Chapter 19 Kernicterus in older children and adults.- Chapter 20 Cerebral palsy and counseling.- Chapter 21 Neurological sequelae from jaundice.- Chapter 22 Neurobehavioral teratology.- Chapter 23 Gene therapy for hyperbilirubinemia.- Chapter 24 Epilog: Kernicterus: comments and future directions.- Appendix.- References.- Index.